National Immuno-Oncology Clinical Network Project Overview

This document is a project report detailing the collaborative working project between Bristol-Myers Squibb Pharmaceuticals Limited and Clatterbridge Cancer Centre NHS Foundation Trust, aimed at establishing the National Immuno-Oncology Clinical Network. The report outlines the project's background, objectives, structure, and expected outcomes. It describes how the initiative emerged from an informal network of clinicians seeking to improve the management of immunotherapy in the UK. The project aims to create an autonomous organization by the end of a six-month period, focusing on service development, clinical governance, policy, medical education, and research. The report details the necessary infrastructure, including the identification of a project management team and the establishment of processes to support the network's independence. Additionally, it highlights the benefits for patients, the NHS, and Bristol-Myers Squibb, emphasizing the importance of collaboration and shared resources. The document concludes with a summary of the project's achievements, including the network's charitable status and the establishment of a Board of Trustees.